Home / Business and Economy / India Poised to Lead Global Homoeopathy Market
India Poised to Lead Global Homoeopathy Market
8 Mar
Summary
- India's homoeopathy sector growth driven by expertise and networks.
- AYUSH Premium Mark and NABL accreditation are key quality differentiators.
- Indian brands aim to challenge European dominance with certified quality.
India is set to lead the global homoeopathy market, bolstered by its strong clinical expertise and practitioner networks. Historically, German brands held a premium reputation, but India is now challenging this dominance through its robust quality frameworks. The AYUSH Premium Mark and NABL accreditation ensure global-level compliance in manufacturing, safety, and quality control.
With over 2.5 lakh registered practitioners and extensive clinical data, India possesses a unique experiential advantage. This, combined with certified quality, lends scientific credibility to Indian homoeopathic products. Companies like Adven Biotech are leading this transformation, becoming the first to achieve both AYUSH Premium Mark and NABL certifications.
These certifications serve as global passports, elevating Indian brands to the same platform as leading German manufacturers. India offers cost-efficiency alongside quality, making its products more accessible. The focus is shifting from legacy to reliability, transparency, and global compliance, positioning India to potentially outperform established European competitors.
